InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Schorno Dean L, Chief Financial Officer. Officer active across 1 company, notably RIGEL PHARMACEUTICALS INC. In total, 2 filings have been published. History available since 24 January 2022. The latest transaction was disclosed on 24 January 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
50,000 shares0Common StockSEC:0001567619-22-001782:0
50,000 shares0Common StockSEC:0001567619-22-001782
2 of 2 declarations
About Schorno Dean L
Dean L. Schorno is the Executive Vice President and Chief Financial Officer of Rigel Pharmaceuticals Inc. In this role, he oversees the company's financial operations, including cash management and financial reporting. With expertise in the pharmaceutical sector, he contributes to the financial strategy of Rigel Pharmaceuticals, which develops treatments for serious diseases.
